Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX with Bevacizumab and Imatinib in First-line Metastatic Colorectal Cancer
NCT00784446Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Apr 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in colorectal cancer (CRC), sponsored by University of Cologne. Started Apr 2008; status: completed.
02
Drugs
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00784446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784446.